MDGL · Madrigal Pharmaceuticals, Inc. · Executive Compensation

$467.54 +20.45 (+4.57%) At close · Oct 20

Russell 1000 member Rebalance outlook locked

Market Cap

$10.80B

23.10M

Volume · Oct 20 408.04K Avg daily vol (3M) 294.81K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Bill Sibold	President and Chief Executive Officer	$918,531	—	$12,297,850	$4,537,146	$1,438,814	$14,000	$19,206,341
David Soergel	Executive Vice President and Chief Medical Officer	$418,182	$75,000	$5,911,809	$2,201,587	$584,100	—	$9,190,678
Rebecca Taub	Senior Scientific and Medical Advisor and Former President, Research & Development and Chief Medical Officer	$617,500	—	$4,124,382	$1,521,590	$604,544	—	$6,868,016
Mardi Dier	Executive Vice President and Chief Financial Officer	$566,042	—	$3,561,539	$1,313,997	$554,165	$89,346	$6,085,089
Carole Huntsman	Executive Vice President and Chief Commercial Officer	$540,313	—	$3,186,937	$1,175,671	$528,976	$9,839	$5,441,736
Shannon Kelley	Executive Vice President and Chief Legal Counsel	$535,167	—	$2,999,636	$1,106,611	$523,938	$14,000	$5,179,352

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Bill Sibold	President and Chief Executive Officer	$889,583	—	$7,558,495	$2,805,309	$950,513	$10,350	$12,214,250
Mardi Dier	Executive Vice President and Chief Financial Officer	$464,679	—	$5,676,894	$2,233,273	$296,716	$80,350	$8,751,912
Rebecca Taub	Senior Scientific and Medical Advisor and Former President, Research & Development and Chief Medical Officer	$596,209	—	$3,570,078	$1,324,919	$426,000	$50,000	$5,967,206
Shannon Kelley	Executive Vice President and Chief Legal Counsel	$441,655	—	$1,949,994	$1,949,953	$325,925	$6,237	$4,673,764
Carole Huntsman	Executive Vice President and Chief Commercial Officer	$525,000	—	$2,245,336	$833,280	$335,475	$10,350	$3,949,441

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Bill Sibold	President and Chief Executive Officer	$275,400	$520,000	$31,205,000	—	$268,000	—	$32,268,400
Paul Friedman	Former Chief Executive Officer	$498,846	—	$7,999,867	—	—	$1,064,573	$9,563,286
Remy Sukhija	Former Senior Vice President, Chief Commercial Officer	$387,718	—	$4,500,000	—	—	$2,474,660	$7,362,378
Rebecca Taub	President, Research &^^Development and Chief Medical Officer	$574,108	—	$5,999,900	—	$354,000	—	$6,928,008
Brian J. Lynch	Former Senior Vice President and General Counsel	$501,590	—	$4,500,000	—	$247,000	$17,994	$5,266,584
Alex Howarth	Former Senior Vice President and Chief Financial Officer	$498,829	—	$4,500,000	—	$246,000	$17,194	$5,262,023
Carole Huntsman	Chief Commercial Officer	$61,922	—	$1,488,852	$1,559,501	$32,000	$79	$3,142,354

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Paul Friedman	Former Chief Executive Officer	$658,021	—	—	$4,239,900	$497,464	—	$5,395,385
Brian J. Lynch	Former Senior Vice President and General Counsel	$467,604	—	—	$3,994,400	$282,807	$13,338	$4,758,149
Rebecca Taub	President, Research &^^Development and Chief Medical Officer	$535,208	—	—	$3,725,055	$404,618	—	$4,664,881
Remy Sukhija	Former Senior Vice President, Chief Commercial Officer	$482,813	—	—	$2,725,650	$292,005	$10,381	$3,510,849
Alex Howarth	Former Senior Vice President and Chief Financial Officer	$465,625	—	—	$2,725,650	$281,250	$10,381	$3,482,906

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Alex Howarth	Former Senior Vice President and Chief Financial Officer	$281,250	$75,000	—	$6,526,500	$241,200	$7,854	$7,131,804
Paul Friedman	Former Chief Executive Officer	$627,650	—	—	$4,267,500	$423,239	—	$5,318,389
Rebecca Taub	President, Research &^^Development and Chief Medical Officer	$510,500	—	—	$3,755,400	$344,246	—	$4,610,146
Marc R. Schneebaum	Former Senior Vice President, Chief Financial Officer	$369,824	—	—	$2,731,200	$91,060	$512,705	$3,704,789
Brian J. Lynch	Former Senior Vice President and General Counsel	$445,333	—	—	$2,731,200	$240,610	$13,338	$3,430,481
Remy Sukhija	Former Senior Vice President, Chief Commercial Officer	$461,250	—	—	$2,048,400	$248,436	$10,381	$2,768,467

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Paul Friedman	Chairman and Chief Executive Officer	$603,500	—	—	$3,468,500	$463,446	—	$4,535,446
Brian J. Lynch	Senior Vice President and General Counsel	$425,417	—	—	$3,749,840	$260,946	$11,690	$4,447,893
Rebecca Taub	President, Research &^^Development and Chief Medical Officer	$490,833	—	—	$3,052,280	$339,230	—	$3,882,343
Remy Sukhija	Senior Vice President, Chief Commercial Officer	$337,500	$100,000	—	$2,724,000	$274,680	$2,722	$3,438,902
Marc R. Schneebaum	Former Senior Vice President, Chief Financial Officer	$435,000	—	—	$2,219,840	$267,233	$18,399	$2,940,472

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Paul Friedman	Chairman and Chief Executive Officer	$584,000	—	—	$5,122,000	$387,192	—	$6,093,192
Rebecca Taub	President, Research &^^Development and Chief Medical Officer	$463,948	—	—	$4,531,120	$274,775	—	$5,269,843
Brian J. Lynch	Senior Vice President and General Counsel	$358,602	—	—	$3,506,859	$192,602	$10,574	$4,068,637
Marc R. Schneebaum	Former Senior Vice President, Chief Financial Officer	$421,000	—	—	$2,868,320	$223,298	$20,034	$3,532,652
Marc R	Schneebaum Senior Vice President, Chief Financial Officer	$421,000	—	—	$2,868,320	$223,298	$20,034	$3,532,652

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Paul Friedman	Chairman and Chief Executive Officer	$416,666	—	—	$4,907,500	$304,500	—	$5,628,666
Rebecca Taub	President, Research &^^Development and Chief Medical Officer	$385,416	—	—	$3,729,700	$225,330	—	$4,340,446
Marc R	Schneebaum Senior Vice President, Chief Financial Officer	$380,250	—	—	$2,748,200	$222,314	$15,336	$3,366,100
Marc R. Schneebaum	Senior Vice President, Chief Financial Officer	$380,250	—	—	$2,748,200	$222,314	$15,336	$3,366,100

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Paul Friedman	Chairman and Chief Executive Officer	$400,000	—	—	$629,424	$335,000	$558	$1,364,982
Rebecca Taub	President, Research & Development^^ and Chief Medical Officer,	$370,000	—	—	$473,337	$247,900	$558	$1,091,795
Marc R	Schneebaum Senior Vice President, Chief Financial Officer	$365,000	—	—	$346,437	$244,550	$14,307	$970,294

Executive changes

Person	Role	Change	Effective	Filed
John C. Reed	Class II director	Appointed	2026-08-11	2026-08-12
Daniel J. Brennan	Class I director	Appointed	2026-04-22	2026-04-28
Julian C. Baker	Class I director	Appointed	2026-04-22	2026-04-28
Daniel J. Brennan	Class II director	Resigned	2026-04-22	2026-04-28
Julian C. Baker	Class III director	Resigned	2026-04-22	2026-04-28
Rita Thakkar	Senior Vice President and Chief Accounting Officer	Appointed	2026-01-12	2025-12-11
Dr. Rebecca Taub	Senior Scientific and Medical Advisor	Appointed	2025-04-21	2025-04-17
Fred Craves, Ph.D.	Board of Directors	Resigned	2025-07-01	2025-03-11
Fred B. Craves, Ph.D.	Class II Nominee	Appointed	2024-06-25	2024-06-27
Rebecca Taub, M.D.	Class II Nominee	Appointed	2024-06-25	2024-06-27
Bill Sibold	Class II Nominee	Appointed	2024-06-25	2024-06-27
Mardi C. Dier	Senior Vice President and Chief Financial Officer	Appointed	2024-03-11	2024-02-28
Bill Sibold	member of the Board	Appointed	2023-09-08	2023-09-13
Bill Sibold	President and Chief Executive Officer	Appointed	2023-09-08	2023-09-13
Julian Baker	independent Chairman of the Board of Directors	Appointed	2023-06-15	2023-06-20
Raymond Cheong	Class III director	Appointed	2023-06-15	2023-06-20
Julian Baker	Class III director	Appointed	2023-06-15	2023-06-20
David Milligan, Ph.D.	Class III director on the Board of Directors	Resigned	2023-06-15	2023-06-20
Keith R. Gollust	Class III director on the Board of Directors	Resigned	2023-06-15	2023-06-20

Leadership

Bill Sibold CEO, Board Member
Julian C. Baker Chairman, Board Member
Mardi Dier CFO
Brian J. Lynch General Counsel
Rita Thakkar Chief Accounting Officer
Daniel J. Brennan Board Member
Fred B. Craves, Ph.D. Board Member
Jacqualyn A. Fouse Board Member
Jacqualyn Fouse, Ph.D. Board Member
James M. Daly Board Member
John C. Reed Board Member
John C. Reed, M.D., Ph.D. Board Member
Julian Baker Board Member
Paul Friedman Board Member
Raymond Cheong Board Member
Rebecca Taub Board Member
Rebecca Taub, M.D. Board Member
Richard S. Levy Board Member

Key facts CIK 1157601 CUSIP 558868105 13F (30d) 48 filings 48 filers Visit website Investor relations